Haotian Liao

Department of Liver Surgery, Sichuan University

Research Area

Biography

Haotian Liao has not added Biography.
If you are Haotian Liao and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
Sofosbuvir in combination with daclatasvir in liver transplant recipients with HCV infection: A systematic review and meta-analysis. Clinics and research in hepatology and gastroenterology\| PubMed ID: 28082137	2017
Exosomal MicroRNA-10a Is Associated with Liver Regeneration in Rats through Downregulation of EphA4. Chinese medical journal\| PubMed ID: 29451151	2018
Identification of The Aberrantly Expressed LncRNAs in Hepatocellular Carcinoma: A Bioinformatics Analysis Based on RNA-sequencing. Scientific reports\| PubMed ID: 29599483	2018
OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis. Oncoimmunology\| PubMed ID: 29632718	2018
Prognostic impact of preoperative anemia on upper tract urothelial carcinoma. Medicine\| PubMed ID: 30212968	2018
Nicotinamide induces liver regeneration and improves liver function by activating SIRT1. Molecular medicine reports\| PubMed ID: 30483782	2019
Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma. EBioMedicine\| PubMed ID: 30665854	2019
LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop. Cancer research\| PubMed ID: 31101763	2019
Preoperative Radiomic Approach to Evaluate Tumor-Infiltrating CD8 T Cells in Hepatocellular Carcinoma Patients Using Contrast-Enhanced Computed Tomography. Annals of surgical oncology\| PubMed ID: 31520208	2019
Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes. Frontiers in oncology\| PubMed ID: 31572677	2019
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Molecular cancer\| PubMed ID: 31856849	2019
Classification and Prognosis Prediction from Histopathological Images of Hepatocellular Carcinoma by a Fully Automated Pipeline Based on Machine Learning. Annals of surgical oncology\| PubMed ID: 31916093	2020
Deep learning-based classification and mutation prediction from histopathological images of hepatocellular carcinoma. Clinical and translational medicine\| PubMed ID: 32536036	2020
Higher expression of cell division cycle-associated protein 5 predicts poorer survival outcomes in hepatocellular carcinoma. Aging\| PubMed ID: 32694239	2020
Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans. Hepatology (Baltimore, Md.)\| PubMed ID: 33368437	2021
Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR. Theranostics\| PubMed ID: 33391541	2021
Cumulative damage effect of jaundice may be an effective predictor of complications in patients undergoing radical resection of Bismuth type II or above hilar cholangiocarcinoma. Annals of translational medicine\| PubMed ID: 34164495	2021
Integrated proteogenomic analysis revealed the metabolic heterogeneity in noncancerous liver tissues of patients with hepatocellular carcinoma. Journal of hematology & oncology\| PubMed ID: 34895304	2021
Efficacy and Safety of Second-line Treatments in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: A Meta-analysis. Journal of clinical and translational hepatology\| PubMed ID: 34966650	2021
CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma. Molecular cancer\| PubMed ID: 35039066	2022
ASO Author Reflections: Characterizing the Genomic Alterations in Hepatocellular Carcinoma by Contrast-Enhanced CT. Annals of surgical oncology\| PubMed ID: 35239101	2022
Predicting Genomic Alterations of Phosphatidylinositol-3 Kinase Signaling in Hepatocellular Carcinoma: A Radiogenomics Study Based on Next-Generation Sequencing and Contrast-Enhanced CT. Annals of surgical oncology\| PubMed ID: 35286532	2022
Nanostructured particles assembled from natural building blocks for advanced therapies. Chemical Society reviews\| PubMed ID: 35471996	2022
Long noncoding RNA TLNC1 promotes the growth and metastasis of liver cancer via inhibition of p53 signaling. Molecular cancer\| PubMed ID: 35477447	2022
Supramolecular nanoarchitectonics of phenolic-based nanofiller for controlled diffusion of versatile drugs in hydrogels. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 37422124	2023
Correction: CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma. Molecular cancer\| PubMed ID: 37573299	2023
Whole-Genome DNA Methylation Profiling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers. Cancer research\| PubMed ID: 38471085	2024
CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis. Cancer research\| PubMed ID: 39693605	2025
Multisite long-read sequencing reveals the early contributions of somatic structural variations to HBV-related hepatocellular carcinoma tumorigenesis. Genome research\| PubMed ID: 40037842	2025